"Kendle has conducted more than
600 Phase IIIB and IV
studies,
recruiting more than 1.5 million patients."
In the competitive and fast-moving world of clinical development, you need a CRO partner that will focus on delivering efficiencies and consistent value. Whether it’s a large, complex global Phase II-IV study or a smaller, regional trial, Kendle has the unrivaled experience, therapeutic expertise and global capabilities to ensure successful partnerships.
Our approach is based on anticipating needs and communicating effectively to drive innovation and accelerate productivity, making us not just a helping hand – but also a "helping brain".